Grand Rounds, April 30, 2025


April 29, 2026

Presentation Title: Neoadjuvant Breakthroughs, Long-term Burdens: The Impact of Financial Toxicity on Quality of Survivorship

Speaker: Menghan Zhao, MD, and Nathaniel Deboever, MD, MS


Date: Thursday, April 30, 2025
Time: 7:00 AM ‐ 8:00 AM
Location: Medical School Building
Learning Format: In‐Person


Learning Objectives:
At the conclusion of this activity, participants should be able to:

  • Evaluate the efficacy of immunotherapy in lung, esophagus, and breast cancer
  • Quantify and grade financial toxicity
  • Implement financial navigation strategies

Accreditation Statement: McGovern Medical School at the University of Texas Health Science Center at Houston is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education or physicians.


Credit Designation: McGovern Medical School at the University of Texas Health Science Center at Houston designates this live activity for 1 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


ABS MOC Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirement (s) of the American Board of Surgery’s Continuous Certification program.  It is the CME activity provider’s responsibility to submit learner completion information to ACGME for the purpose of granting ABS credit.

Disclosure of Financial Relationships:

Speaker: Nathaniel Deboever, MD, and Menghan Zhao,  Residents General Surgery, Department of Surgery, Neoadjuvant breakthroughs, long-term burdens: the impact of financial toxicity on quality of survivorship has no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, or distributing healthcare products used by or on patients to disclosure.

Planners Committee Members: David Wainwright, MD, Sasha D. Adams, MD, Acute Care Surgery Program Director, General Surgery Residency Vice-Chair for Education, Department of Surgery, Lillian Kao, MD, Professor, Surgery, Natalie Drucker, MD and Tamara Saunders, MD have no financial relationship(s) with ineligible companies who primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Mark Hobeika, MD –  TransMedics, Inc – Contracted Research – Relationship Ended

Steven Canfield, MD – AngioDynamics – Advisory Committee Member – Relationship Has Not Ended

Erik Wilson, MD – Johnson & Johnson – Teaching – Relationship Has Not Ended;  Gore – Teaching – Relationship Has Not Ended; Medtronic – Teaching – Relationship Has Not Ended; GI Windows – Independent Contractor – Relationship Has Not Ended; Boston Scientific – Teaching – Relationship Has Not Ended

Laura Moore, MD – Frontline Medical Technologies – Advisory Committee Member – Relationship Has Not Ended

Shinil Shah, DO – GI Windows – Contracted Research – Relationship Has Not Ended

Any financial relationship that was found to be relevant has been mitigated.


 


Related topics